KRSNAA DIAGNOSTICS share price has zoomed 9% and is presently trading at Rs 685.0.
Meanwhile, the BSE HEALTHCARE index is at 37,432.2 (up 0.7%).
Among the top gainers in the BSE HEALTHCARE index today are FDC (up 6.5%) and IPCA Labs (up 3.4%).
AARTI DRUGS (down 1.7%) and CAPLIN POINT (down 1.5%) are among the top losers today.
Over the last one year, KRSNAA DIAGNOSTICS has moved up from Rs 584.5 to Rs 685.0, registering a gain of Rs 100.5 (up 17.2%).
On the other hand, the BSE HEALTHCARE index has moved up from 25,627.6 to 37,432.2, registering a gain of 46.1% during the last 12 months.
The top gainers among the BSE HEALTHCARE index stocks during this same period were Glenmark Pharma (up 92.9%), Cadila Healthcare (up 88.4%) and GSK Pharma (up 85.0%).
Must See: These Segments are Witnessing Incredible Growth with Modi's Push
The BSE Sensex is at 79,967.7 (up 0.7%).
The top gainers among the BSE Sensex today are HDFC Bank (up 2.6%) and Axis Bank (up 2.3%). The most traded stocks in the BSE Sensex are Tata Steel and SBI.
In the meantime, NSE Nifty is at 24,281.8 (up 0.7%). Tata Consumer Products and HDFC Bank are among the top gainers in NSE NIFTY.
Over the last 12 months, the BSE Sensex has moved up from 65,205.1 to 79,967.7, registering a gain of 14,762.7 points (up 22.6%).
KRSNAA DIAGNOSTICS net profit fell 1.0% YoY to Rs 187 million for the quarter ended March 2024, compared to a profit of Rs 189 million a year ago. Net sales rose 24.8% to Rs 1,663 million during the period as against Rs 1,332 million in January-March 2023.
For the year ended March 2023, KRSNAA DIAGNOSTICS reported 9.2% decrease in net profit to Rs 621 million compared to net profit of Rs 684 million during FY22. Revenue of the company grew 7.0% to Rs 4,871 million during FY23.
The current Price to earnings ratio of KRSNAA DIAGNOSTICS, based on rolling 12 month earnings, stands at 38.9.
Equitymaster requests your view! Post a comment on "KRSNAA DIAGNOSTICS Gains 9%; BSE HEALTHCARE Index Up 0.7%". Click here!
Comments are moderated by Equitymaster, in accordance with the Terms of Use, and may not appear
on this article until they have been reviewed and deemed appropriate for posting.
In the meantime, you may want to share this article with your friends!